Technical Analysis for PTHL - Pheton Holdings Ltd

Grade Last Price % Change Price Change
C 4.98 9.45% 0.43
PTHL closed up 9.45 percent on Wednesday, November 20, 2024, on 35 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Stochastic Reached Overbought Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Fell Below 50 DMA Bearish 9.45%
20 DMA Support Bullish 9.45%
Crossed Above 50 DMA Bullish 7.33%
Crossed Above 20 DMA Bullish 14.48%

   Recent Intraday Alerts

Alert Time
50 DMA Support about 18 hours ago
Rose Above Previous Day's High about 18 hours ago
Rose Above Upper Bollinger Band about 18 hours ago
Rose Above 50 DMA about 18 hours ago
Up 3% about 18 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD
Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Cancer Tumor Radiation Radiation Therapy Medical Physics Healthcare Solution Brachytherapy Malignant Tumors

Is PTHL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.45
52 Week Low 3.32
Average Volume 208,005
200-Day Moving Average 0.00
50-Day Moving Average 4.67
20-Day Moving Average 4.31
10-Day Moving Average 4.42
Average True Range 0.50
RSI (14) 57.45
ADX 16.1
+DI 21.62
-DI 13.23
Chandelier Exit (Long, 3 ATRs) 3.59
Chandelier Exit (Short, 3 ATRs) 5.04
Upper Bollinger Bands 4.88
Lower Bollinger Band 3.75
Percent B (%b) 1.09
BandWidth 26.28
MACD Line 0.01
MACD Signal Line -0.07
MACD Histogram 0.0773
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.68
Resistance 3 (R3) 5.65 5.37 5.57
Resistance 2 (R2) 5.37 5.19 5.39 5.53
Resistance 1 (R1) 5.18 5.08 5.27 5.21 5.49
Pivot Point 4.90 4.90 4.95 4.92 4.90
Support 1 (S1) 4.71 4.72 4.81 4.75 4.47
Support 2 (S2) 4.43 4.61 4.45 4.43
Support 3 (S3) 4.24 4.43 4.39
Support 4 (S4) 4.28